Le Bénéfice D'Exploitation Changement Date
Abbott USD 2.25B 73M 2025-12
AngioDynamics USD -9.97M 1.12M 2025-02
AtriCure USD 208K 4.03M 2025-09
Baxter International USD 201.2M 70.8M 2025-09
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.24B 203M 2025-12
Chart Industries USD 177.5M 8M 2025-09
Cooper Companies USD 140.4M 35.3M 2025-09
Dexcom USD 242.5M 29.9M 2025-09
Edwards Lifesciences USD 425.1M 5.8M 2025-09
Globus Medical USD -117.52M 8.43M 2025-09
Inogen USD -7.79M 728K 2024-09
Insulet USD 117.7M 3.4M 2025-09
Masimo USD 83.6M 19.1M 2025-09
Medtronic USD 1.7B 100M 2025-09
Orthofix International USD -84.62M 65.72M 2024-12
Philips EUR 719M 390M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Steris USD 278M 7.1M 2025-12
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD -22.86M 9M 2025-09
Teleflex USD -408.9M 586.38M 2025-09
X T L Biopharmaceuticals USD -812K 48K 2024-12
Zimmer Biomet Holdings USD 302.9M 35.4M 2025-12


Inogen Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.